German National Cohort (NAKO)

German National Cohort (NAKO)
Name	German National Cohort (NAKO)
Country	Germany
Established	2014
Participants	~200,000
Type	Prospective cohort study
Headquarters	Berlin

German National Cohort (NAKO) is a large-scale prospective population-based cohort study in Germany established to investigate the causes of major chronic diseases through long-term follow-up of participants. It integrates epidemiological, clinical, imaging, genetic, and environmental data to enable research on cardiovascular disease, cancer, diabetes mellitus, and other non-communicable diseases alongside social and environmental determinants. The study is coordinated by a multi-institutional network involving academic centers and research institutes across Berlin, Munich, Hamburg, and other German cities.

Overview

The project was initiated to create a resource comparable in scope to cohorts such as the Framingham Heart Study, the UK Biobank, the Nurse's Health Study and the Rotterdam Study, aiming to support translational research involving clinical partners like the Charité – Universitätsmedizin Berlin and population research centers including the Helmholtz Zentrum München. NAKO enrolls adults aged 20–69 to produce longitudinal data for epidemiologists, geneticists, radiologists, and public health researchers affiliated with institutions like the Max Planck Society, the Robert Koch Institute, and the German Cancer Research Center. Collaborative links extend to international studies such as the European Prospective Investigation into Cancer and Nutrition and consortia that include the International Agency for Research on Cancer.

History and Funding

Conceived in the early 2010s with conceptual contributions from researchers at LMU Munich, University of Heidelberg, and University of Leipzig, the cohort received major funding through federal and state programs linked to agencies including the Federal Ministry of Education and Research (Germany), the German Research Foundation, and the BMBF. Establishment involved coordination with clinical sites at centers like Universitätsklinikum Hamburg-Eppendorf, University Hospital Tübingen, and research organizations such as the Leibniz Association. The funding model resembles investments seen in initiatives like the Human Genome Project and the Precision Medicine Initiative, enabling large-scale imaging and biospecimen archiving.

Study Design and Methods

NAKO employs a prospective design with baseline examinations, extensive questionnaires, physical measurements, standard laboratory assays, and advanced imaging modalities including whole-body magnetic resonance imaging comparable to imaging protocols used in studies at Mayo Clinic and Massachusetts General Hospital. Multi-omics data generation aligns with pipelines used at the Broad Institute, and genetic analyses use reference frameworks like the 1000 Genomes Project and panels from the HapMap Project. Data harmonization and statistical approaches reference methods applied in projects at the Wellcome Sanger Institute and the European Molecular Biology Laboratory to enable pooled analyses with cohorts such as the Nurses' Health Study II and the Avon Longitudinal Study of Parents and Children.

Participant Recruitment and Cohorts

Recruitment targeted geographically stratified population samples from registration offices in cities including Cologne, Frankfurt am Main, Stuttgart, and Dresden, utilizing outreach strategies similar to those of the Framingham Heart Study and the Whitehall Study. The full NAKO cohort includes a main cohort and intensively examined subcohorts with over-sampling of older participants to parallel demographic sampling seen in the Cardiovascular Health Study. Collaborating researchers come from universities such as University of Bonn, University of Münster, and RWTH Aachen University.

Data Collection and Biobank

Biospecimens (blood, urine, saliva) are collected, processed, and stored in centralized biobanks operated with quality standards akin to those at the European Biobanking and Biomolecular Resources Research Infrastructure and the Biobanking and Biomolecular Resources Research Infrastructure – Netherlands. Imaging data, including MRI and computed tomography, are archived following protocols similar to imaging repositories at the European Radiology Network. Linkage to routine health registries leverages infrastructure comparable to systems used by the Statistisches Bundesamt (Germany) and national cancer registries coordinated with the German Centre for Cancer Registry Data.

Key Findings and Publications

NAKO publications have reported insights into risk factor distributions and early biomarkers relevant to coronary artery disease, stroke, chronic obstructive pulmonary disease, and metabolic disorders, contributing to literature alongside landmark reports from The Lancet, Nature Medicine, and European Heart Journal. Collaborative analyses have appeared with co-authors from institutions like University College London, Harvard T.H. Chan School of Public Health, and the Karolinska Institutet, enabling pooled meta-analyses comparable to those conducted by the Global Burden of Disease Study and consortium efforts such as the CHARGE Consortium.

Governance, Ethics, and Data Access

Governance involves scientific advisory boards with experts from organizations such as the German Medical Association, the Academy of Sciences Leopoldina, and representatives of partner universities including University of Freiburg and Technical University of Munich. Ethical oversight follows standards from bodies like the European Commission ethics frameworks and national regulations enforced by ethics committees at sites like Charité – Universitätsmedizin Berlin. Data access policies permit controlled researcher access similar to models used by the UK Biobank and the Database of Genotypes and Phenotypes, with application review by data access committees to protect participant privacy under principles aligned with the General Data Protection Regulation.

Category:Epidemiology